<DOC>
	<DOC>NCT02961634</DOC>
	<brief_summary>Single-center study, single blind, comparative with the objective of evaluating the efficacy and safety of an investigational product as an adjunct in the treatment of onychomycosis improvement of 90 days Â± 2 days.</brief_summary>
	<brief_title>Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Ciclopirox</mesh_term>
	<criteria>Volunteers of both sexes; Volunteers aged 1865 years; Volunteers with onychomycosis confirmed by positive direct mycological nail of hands or feet; Agreement to comply with the test procedures and attend the clinic in the days and times for certain applications and / or assessments; Understand, consent and sign the Instrument of Consent of Clarified. Pregnancy or risk pregnancy / lactation; Use of antiinflammatory / immunosuppressive drugs (in the last 30 days and during the study); Concomitant nail pathologies (psoriasis, lichen planus, etc.); Systemic conditions that may compromise the growth of the nail (vascular disease, diabetes, etc.); Irritation History to similar products to the investigational product; Treatment with antifungal medication prior to the study (up to 12 weeks for systemic medications and topical medications for four weeks); Other conditions considered by the investigator physician as reasonable for the disqualification of the individual's participation in the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>onychomycosis</keyword>
	<keyword>nail</keyword>
</DOC>